Expert Interviews

The ongoing challenges of mental health, artificial intelligence, and the addressing of social determinants of health are key themes of pediatric health care are topics of discussion with Matthew Davis, MD, FAAP in this video interview.

Brittany Bruggeman, MD, emphasizes that many patients with type 1 diabetes are unaware of the availability of advanced technologies like CGMs and automated insulin delivery systems.

John Loiselle, MD, discusses careful pediatric exams, the growing use of ultrasound in emergency departments, and the rise of mental health cases affecting care.

Brittany Bruggeman, MD, highlighted the ability to predict type 1 diabetes months to years in advance through islet autoantibodies, and how the pediatrician can play a role.

Contemporary Pediatrics' editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, talks RSV immunization and the availability of prevention tools.

Steven Selbst, MD, discusses a recent trend in emergency medicine where non-operative management of appendicitis is being considered as an alternative to traditional surgery.

Angela Chun, MEd, MD, FAAP, discusses common causes of pediatric joint pain, serious red flags, and the importance of timely diagnosis of conditions like JIA and silent uveitis.

At the 2024 AAP National Conference, Steven Selbst, MD, highlighted the rise in accidental THC ingestions among children, urging pediatricians to counsel parents on the dangers of improperly stored THC gummies that resemble candy.

Tanya Altmann, MD, discusses California's AB 899 law requiring baby food heavy metal testing, urging a balance between safety and maintaining nutrition quality.

Angela Chun, MEd, MD, FAAP, shares tips on distinguishing mechanical vs inflammatory joint pain in children, emphasizing timing, activity, and key physical exam maneuvers.

Rana Hamdy, MD, discussed her session at the 2024 AAP meeting, highlighting treatment duration with antibiotics for community-acquired pneumonia as well as the importance of understanding amoxicillin allergy.

John Loiselle, MD, FAAP, discusses pediatric musculoskeletal injuries, focusing on growth plates and age-specific anatomy at the 2024 AAP Conference.

Lori Byron, MD, emphasizes the harmful effects of extreme heat and wildfire smoke on children's health, urging education, sustainability, and collective action.

Tanya Altmann, MD, discusses the growing issue of childhood obesity in the United States and the benefits of new weight management medications.

A look into CDC numbers for increasing pertussis cases in the United States, along with commentary from our editor-in-chief, Tina Tan, MD, FAAP, FIDSA, FPIDS.

At AAP 2024, Rana Hamdy, MD, shared insights from her session, "Diagnosis and Treatment of Community-Acquired Pneumonia."

"It's unfortunate now that emergency departments need to prepare for disasters like that, and physicians everywhere need to prepare... They may need to come in."

Our editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, previews some of the American Academy of Pediatrics National Conference & Exhibition, taking place right now in Orlando, Florida.

Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to discuss potential advantages of LUM-201 as it goes through the clinical pipeline.

The panel examines potential long-term effects of central precocious puberty treatment on bone density and spermatogenesis in male patients.

Experts offer recommendations for supporting central precocious puberty patients in managing the social stigma and challenges associated with their condition.

Experts address common misconceptions about the timing of central precocious puberty treatment initiation and discontinuation, highlighting research on outcomes for therapy started before age 7 and continued beyond age 12.

Linda DiMeglio, MD, MPH, joined us to discuss the “Consensus Guidance for Monitoring Persons with Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes."

Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to talk PGHD and the role of the pediatrician when it comes to treatment.

Alan Percy, MD, discusses where the general provider comes in when treating Rett syndrome and prescribing trofinetide (Daybue).

Alan Percy, MD, discussed what the FDA approval of trofinetide (Daybue) has meant to patients with Rett syndrome aged 2 years and older.

Pediatric endocrinologists explore comprehensive, individualized treatment strategies for Central Precocious Puberty that extend beyond considerations of chronological and bone age.

The panel examines the efficacy and safety profiles of gonadotropin-releasing hormone analogue (GnRHa) treatments in managing Central Precocious Puberty.

Key opinion leaders analyze current treatment guidelines for Central Precocious Puberty while offering insights on navigating treatment selection in scenarios lacking established protocols.

The panel explores the impact of early versus delayed diagnosis and treatment initiation on long-term outcomes in Central Precocious Puberty patients.